Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis

Cancer Letters

Volumn 296, Issue 1, 2010, Pages 27-34

  Takayama, Yuichi ^a   Kokuryo, Toshio ^a   Yokoyama, Yukihiro ^a   Ito, Satoko ^a   Nagino, Masato ^a   Hamaguchi, Michinari ^a   Senga, Takeshi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholangiocarcinoma; Cisplatin; DNA damage; Gemcitabine; TLK1

Indexed keywords

CISPLATIN; HISTONE H2AX; PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA; TOUSLED LIKE KINASE 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DRUG SENSITIZATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; CISPLATIN; DEOXYCYTIDINE; DNA REPAIR; DNA REPLICATION; FIBROBLASTS; FORESKIN; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HUMANS; IN SITU NICK-END LABELING; MALE; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 77954761362     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.03.011     Document Type: Article

References (27)

1. Khan S.A., Thomas H.C., Davidson B.R., Taylor-Robinson S.D. Cholangiocarcinoma. Lancet 2005, 366:1303-1314.
2. Giuliani F., Gebbia V., Maiello E., Borsellino N., Bajardi E., Colucci G. Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM). Ann. Oncol. 2006, 17:73-77.
3. Eckel R.M., Schmid F. Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials. Br. J. Cancer 2007, 96:896-902.
4. Rabik C.A., Dolan M.E. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat. Rev. 2007, 33:9-23.
5. Carmichael J. The role of gemcitabine in the treatment of other tumours. Br. J. Cancer 1998, 78:21-25.
6. Roe J.L., Rivin C.J., Sessions R.A., Feldmann K.A., Zambryski P.C. The Tousled gene in A. thaliana encodes a protein kinase homolog that is required for leaf and flower development. Cell 1993, 75:939-950.
7. Roe J.L., Nemhauser J.L., Zambryski P.C. TOUSLED participates in apical tissue formation during gynoecium development in Arabidopsis. Plant Cell 1997, 9:335-353.
8. Sillje H.H., Takahashi K., Tanaka K., Van Houwe G., Nigg E.A. Mammalian homologues of the plant Tousled gene code for cell-cycle-regulated kinases with maximal activities linked to ongoing DNA replication. EMBO J. 1999, 18:5691-5702.
9. Ehsan H., Reichheld J.P., Durfee T., Roe J.L. TOUSLED kinase activity oscillates during the cell cycle and interacts with chromatin regulators. Plant Physiol. 2004, 134:1488-1499.
10. Groth A., Lukas J., Nigg E.A., Sillje H.H., Wernstedt C., Bartek J., Hansen K. Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint. EMBO J. 2003, 22:1676-1687.
11. Krause D.R., Jonnalagadda J.C., Gatei M.H., Sillje H.H., Zhou B.B., Nigg E.A., Khanna K. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1. Oncogene 2003, 22:5927-5937.
12. Li Y., DeFatta R., Anthony C., Sunavala G., De Benedetti A. A translationally regulated Tousled kinase phosphorylates histone H3 and confers radioresistance when overexpressed. Oncogene 2001, 20:726-738.
13. Sillje H.H., Nigg E.A. Identification of human Asf1 chromatin assembly factors as substrates of Tousled-like kinases. Curr. Biol. 2001, 11:1068-1073.
14. Sunavala-Dossabhoy G., De Benedetti A. Tousled homolog, TLK1, binds and phosphorylates Rad9; TLK1 acts as a molecular chaperone in DNA repair. DNA Repair (Amst) 2009, 8:87-102.
15. Sen S.P., De Benedetti A. TLK1B promotes repair of UV-damaged DNA through chromatin remodeling by Asf1. BMC Mol. Biol. 2006, 7-37.
16. Sunavala-Dossabhoy G., Balakrishnan S.K., Sen S., Nuthalapaty S., De Benedetti A. The radioresistance kinase TLK1B protects the cells by promoting repair of double strand breaks. BMC Mol. Biol. 2005, 6-19.
17. Kokuryo T., Senga T., Yokoyama Y., Nagino M., Nimura Y., Hamaguchi M. Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma. Cancer Res. 2007, 67:9637-9642.
18. Kokuryo T., Yamamoto T., Oda K., Kamiya J., Nimura Y., Senga T., Yasuda Y., Ohno Y., Nakamura Y., Chen M.F., Jan Y.Y., Yeh T.S., Chiu C.T., Hsieh L.L., Hamaguchi M. Profiling of gene expression associated with hepatolithiasis by complementary DNA expression array. Int. J. Oncol. 2003, 22:175-179.
19. Sunavala-Dossabhoy G., Li Y., Williams B., De Benedetti A. A dominant negative mutant of TLK1 causes chromosome missegregation and aneuploidy in normal breast epithelial cells. BMC Cell Biol. 2003, 4-16.
20. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 2000, 10:886-895.
21. Shalom S., Don Tlk J. A novel evolutionarily conserved murine serine threonine kinase, encodes multiple testis transcripts. Mol. Reprod. Dev. 1999, 52:392-405.
22. Carrera P., Moshkin Y.M., Gronke S., Sillje H.H., Nigg E.A., Jackle H., Karch F. Tousled-like kinase functions with the chromatin assembly pathway regulating nuclear divisions. Genes Dev. 2003, 17:2578-2590.
23. Han Z., Saam J.R., Adams H.P., Mango S.E., Schumacher J.M. The C. elegans Tousled-like kinase (TLK-1) has an essential role in transcription. Curr. Biol. 2003, 13:1921-1929.
24. Wang Y., Liu J., Xia R., Wang J., Shen J., Cao R., et al. The protein kinase TOUSLED is required for maintenance of transcriptional gene silencing in Arabidopsis. EMBO Rep. 2007, 8:77-83.
25. Ewald B., Sampath D., Plunkett W. ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance. Cancer Res. 2008, 68:7947-7955.
26. Karnitz L.M., Flatten K.S., Wagner J.M., Loegering D., Hackbarth J.S., Arlander S.J., et al. Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. Mol. Pharmacol. 2005, 68:1636-1644.
27. Ewald B., Sampath D., Plunkett W. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Mol. Cancer Ther. 2007, 6:1239-1248.